In order to develop new technologies Scienion will establish a second development and production site in Dortmund and will move into new facilities in the BioMedizinZentrum Dortmund
Scienion has closed a financing round totaling more than euro 4.5million.
The cash inflow enables the development of new technologies and thus the further expansion of the company.
In order to develop these new technologies Scienion will establish a second development and production site in Dortmund and will move into new facilities in the BioMedizinZentrum Dortmund.
The investment was led by the new investors NRW Bank and S-Venture Capital Dortmund and current VC investor Peppermint.
The VC Fonds Berlin of IBB Beteiligungsgesellschaft and ERP Start Fonds of Kreditanstalt fur Wiederaufbau (KfW) participated in this round together with other existing Scienion investors.
Holger Eickhoff, CEO of Scienion, explains: "We will use the new capital for developing innovative technologies in the field of low level liquid handling and its various applications as we face growing needs in this market.
"The BioMedizinZentrum Dortmund offers attractive conditions for our expansion and that's why we build up a second development and production site here".
"We invest in Scienion because of its convincing business plan, and we are glad to get this innovative company to Nordrhein-Westfalen," says Ernst Gerlach, CEO of NRW Bank.
Joachim Rautter of Peppermint Financial Partners adds: "Since our investment in 2001 we have accompanied Scienion's successful development and with this new round we want to accelerate this positive development.
"Scienion has products and plans with a high market potential in the life science sector and that is the reason why we further invest in the company".
In its first financing round in 2001, Scienion raised start financing of approximately six million euro.
From the beginning of operations, Scienion has generated revenues with its innovative products and services that continually show high rates of growth.
